HK1174532A1 - Compositions comprising botulinum toxin a or b for use in the treatment of osteoporosis a b - Google Patents

Compositions comprising botulinum toxin a or b for use in the treatment of osteoporosis a b

Info

Publication number
HK1174532A1
HK1174532A1 HK13101344.6A HK13101344A HK1174532A1 HK 1174532 A1 HK1174532 A1 HK 1174532A1 HK 13101344 A HK13101344 A HK 13101344A HK 1174532 A1 HK1174532 A1 HK 1174532A1
Authority
HK
Hong Kong
Prior art keywords
osteoporosis
compositions
treatment
botulinum toxin
botulinum
Prior art date
Application number
HK13101344.6A
Other languages
English (en)
Chinese (zh)
Inventor
Marlon P Rimando
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of HK1174532A1 publication Critical patent/HK1174532A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK13101344.6A 2009-09-24 2013-01-31 Compositions comprising botulinum toxin a or b for use in the treatment of osteoporosis a b HK1174532A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24559509P 2009-09-24 2009-09-24
PCT/US2010/049844 WO2011038015A1 (en) 2009-09-24 2010-09-22 Method of treating osteoporosis with a neurotoxin

Publications (1)

Publication Number Publication Date
HK1174532A1 true HK1174532A1 (en) 2013-06-14

Family

ID=43466872

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13101344.6A HK1174532A1 (en) 2009-09-24 2013-01-31 Compositions comprising botulinum toxin a or b for use in the treatment of osteoporosis a b

Country Status (4)

Country Link
EP (1) EP2480250B1 (xx)
CA (1) CA2774951C (xx)
HK (1) HK1174532A1 (xx)
WO (1) WO2011038015A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2649983A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (II)
BR112014025396B1 (pt) 2012-04-13 2020-03-17 Lubrizol Advanced Materials, Inc. Composto, composição cosmética ou farmacêutica, e, uso de um composto
EP2649985A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (III)
EP2649984A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis
GB201303108D0 (en) * 2013-02-21 2013-04-10 Syntaxin Ltd Therapeutics for suppressing osteoporosis

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5437291A (en) 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US6974578B1 (en) 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5766605A (en) 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
US5670484A (en) 1994-05-09 1997-09-23 Binder; William J. Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
EP0758900B1 (en) 1994-05-09 2002-04-10 BINDER, William J. Botulinum toxin FOR REDUCTION OF migraine HEADACHE PAIN
US6063768A (en) 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
EA003512B1 (ru) 1998-03-20 2003-06-26 Кова Ко., Лтд. Желудочная и/или дуоденальная клейкая лекарственная форма
BR9914891A (pt) 1998-10-27 2001-07-17 Mayo Foundation Processos para aperfeiçoamento de cura de ferimento
US6139845A (en) 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6464986B1 (en) 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6299893B1 (en) 2000-04-17 2001-10-09 Marvin Schwartz Method to reduce hair loss and stimulate hair regrowth
US6306423B1 (en) 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US20050214327A1 (en) 2000-06-02 2005-09-29 Allergan, Inc. Neurotoxin-containing suppositories and related methods
US20040033241A1 (en) 2000-06-02 2004-02-19 Allergan, Inc. Controlled release botulinum toxin system
US6423319B1 (en) 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
ES2312651T3 (es) 2001-07-27 2009-03-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Toxina botulinum en el tratamiento o prevencion del acne.
EP1487481A4 (en) 2002-03-01 2005-11-23 Elan Pharm Inc METHOD FOR TREATING NERVE TERMINATION SYNDROMES
US20040009180A1 (en) 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
US20040086532A1 (en) 2002-11-05 2004-05-06 Allergan, Inc., Botulinum toxin formulations for oral administration
US7238357B2 (en) 2002-11-05 2007-07-03 Allergan, Inc. Methods for treating ulcers and gastroesophageal reflux disease
GB2400316A (en) * 2003-04-10 2004-10-13 Richard Markoll Electromagnetic stimulation in patients with osteoporosis

Also Published As

Publication number Publication date
WO2011038015A1 (en) 2011-03-31
EP2480250B1 (en) 2014-04-16
CA2774951C (en) 2014-12-16
EP2480250A1 (en) 2012-08-01
CA2774951A1 (en) 2011-03-31

Similar Documents

Publication Publication Date Title
IL239918A0 (en) Preparations for the treatment of colitis
ZA201006290B (en) Plant health composition
ZA201006292B (en) Plant health composition
PL2424374T3 (pl) Kompozycje środka oczyszczającego i metody jego stosowania
ZA201200054B (en) Therapeutic compounds and compositions
PL2387605T3 (pl) Kompozycja czyszcząca o wysokiej samoadhezji i zapewniająca dodatkowe korzyści
EP2442655A4 (en) COMPOSITIONS AND METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
EP2455446A4 (en) CLEANING AGENT COMPOSITION
IL213990A0 (en) Compositions for decontamination
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
PT2403336E (pt) Composições de tratamento de plantas e métodos para a sua utilização
HK1169306A1 (en) Composition having lipolysis-promoting effect
EP2440216A4 (en) USE OF A COMPOSITION FOR TREATING MUCOSITIS
HK1174532A1 (en) Compositions comprising botulinum toxin a or b for use in the treatment of osteoporosis a b
EP2490536A4 (en) COMPOSITION AND METHOD
EP2534302A4 (en) SURFACE TREATMENT COMPOSITION
EP2174956A4 (en) COMPOSITIONS FOR ANTIFIBRINOLYSIS THERAPY
PL2298090T3 (pl) Kompozycja farmaceutyczna lub nutraceutyczna
GB0917624D0 (en) Decontamination units
PL2263454T3 (pl) Kompozycja uzdatniająca
GB0900786D0 (en) Therapeutic compositions
EP2415482A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF METASTASIS
EP2490704A4 (en) THERAPEUTIC COMPOSITION
ZA201206853B (en) Composition for use in water treatment
GB0902126D0 (en) Hilton 21 dice

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220917